Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B 6C 3F 1 mice

Journal of Immunotoxicology

Volumn 8, Issue 1, 2011, Pages 17-29

  Fair, Patricia A ^a   Driscoll, Erin ^b   Mollenhauer, Meagan A M ^c   Bradshaw, Sarah G ^c   Yun, Se Hun ^d   Kannan, Kurunthachalam ^d   Bossart, Gregory D ^e   Keil, Deborah E ^f   Peden Adams, Margie M ^b,c,g  

^a CENTER FOR COASTAL ENVIRONMENTAL HEALTH AND BIOMOLECULAR RESEARCH   (United States)

^b School of Business and Economics   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e FLORIDA ATLANTIC UNIVERSITY   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NEVADA   (United States)

Author keywords

CBC; cytokines; hematology; immune; Perfluorooctane sulfonate; PFOS; toxicity

Indexed keywords

CD19 ANTIGEN; CD3 ANTIBODY; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFLUOROOCTANESULFONIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH HAZARD; IMMUNE SYSTEM; IMMUNOTOXICITY; INFLAMMATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; UTERUS WEIGHT;

ALKANESULFONIC ACIDS; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROCARBONS; IMMUNOGLOBULIN M; INTERLEUKIN-6; LIVER; MICE; MICE, INBRED STRAINS; ORGAN SIZE; SPLEEN; T-LYMPHOCYTES; THYROID HORMONES; TISSUE DISTRIBUTION;

MUS; OVIS ARIES;

EID: 79751493938     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.3109/1547691X.2010.527868     Document Type: Article

References (100)

1. Andersen, M. E., Butenhof, J. L., Chang, S. C., Farrar, D. G., Kennedy, G. L. Jr Lau, C., Olsen, G.W., Seed, J. and Wallace, K. B. 2008. Perfuoroalkyl acids and related (Pubitemid 351250465)
2. Ankley, G. T., Kuehl, D. W., Kahl M. D., Jensen, K. M., Linnum, A., Leino, R. L. and Villeneuvet, D. A. 2005. Reproductive and developmental toxicity and bioconcentration of perfuorooctanesulfonate in a partial life-cycle test with the fathead minnow (Pimephales promelas). Environ Toxicol Chem., 24(9):2316-2324. (Pubitemid 41191764)
3. Austin, M. E., Kasturi, B. S., Barber, M., Kannan, K., MohanKumar, P. S. and MohanKumar, S. M. 2003. Neuroendocrine efects of perfuorooctane sulfonate in rats. Environ. Health Perspect. 111:1485-1489. (Pubitemid 37120827)
4. Baccam, M. and Bishop, G. A. 1999. Membrane-bound CD154, but not CD40-specifc antibody, mediates NF-kappaB-independent IL-6 production in B-cells. Eur. J. Immunol 29:3855-3866.
5. Baccam, M., Woo, S. Y., Vinson, C. and Bishop, G. A. 2003. CD40-mediated transcriptional regulation of the IL-6 gene in B-lymphocytes: Involvement of NF-kappa B, AP-1, and C/EBP J. Immunol. 170:3099-3108. (Pubitemid 36302185)
6. Bauer, J. 1991. IL-6 in clinical medicine. Ann. Hematol. 62:203-210.
7. Bishop, G. A. and Hostager, B. S. 2003. Te CD40-CD154 interaction in B-cell-T-cell liaisons. Cytokine Growth Factor Rev. 14:297-309.
8. Boss, B. and Neeck, G. 2000. Correlation of IL-6 with the classical humoral dis-ease activity parameters ESR and CRP and with serum cortisol, refecting the activity of the HPA axis in active rheumatoid arthritis. Z. Rheumatol. 59(Suppl. 2):II/62-II/64.
9. Burleson, G. R. and Burleson, F. G. 2008. Testing human biologicals in animal host resistance models. J. Immunotoxicol. 52:3-31.
10. Calafat, A. M., Kuklenyik, Z., Reidy, J. A., Caudill, S. P, Tully, J. S. and Needham, L. L. 2007a. Serum concentrations of 11 polyfuoroalkyl com-pounds in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES). Environ. Sci Technol. 41:2237-2242. (Pubitemid 46595180)
11. Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A. and Needham, L. L. 2007b. Polyfuoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 115:1596-1602.
12. Case, M. T., York, R. G. and Christian, M. S. 2001. Rat and rabbit oral devel-opmental toxicology studies with two perfuorinated compounds. Int. J. Toxicol. 20:101-109. (Pubitemid 32422315)
13. Chang, S. C., Tibodeaux, J. R., Eastvold, M. L., Ehresman, D. J., Bjork, J. A., Froehlich, J. W., Lau, C., Singh, R. J., Wallace, K. B. and Butenhof, J. L. 2008. Tyroid hormone status and pituitary function in adult rats given oral doses of perfuorooctanesulfonate (PFOS). Toxicology 243:330-339. (Pubitemid 50008113)
14. Contin, C., Pitard, V, Delmas, Y., Pelletier, N., Defrance, T., Moreau, J. F., Merville, P. and Dé,chanet-Merville, J. 2003. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients. Immunology 110:131-140. (Pubitemid 37059681)
15. Cunard, R., DiCampli, D., Archer, D. C., Stevenson, J. L., Ricote, M., Glass, C. K. and Kelly, C. J. 2002a. WY14,643, a PPAR alpha ligand, has profound efects on immune responses in vivo. J. Immunol. 169:6806-6812. (Pubitemid 36899265)
16. Cunard, R., Ricote, M., DiCampli, D., Archer, D. C., Kahn, D. A., Glass, C. K. and Kelly, C. J. 2002b. Regulation of cytokine expression by ligands of peroxi-some proliferator activated receptors. J. Immunol. 168:2795-2802. (Pubitemid 34211658)
17. Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J. C., Tedgui, A., Haegeman, G. and Staels, B. 1999. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular infammatory gene response by negative cross-talk with tran-scription factors NF-kappaB and AP-1. J. Biol Chem. 274:32048-32054.
18. DeWitt, J. C., Copeland, C. B. and Luebke, R. W. 2009a. Suppression of humoral immunity by perfuorooctanoic acid is independent of elevated serum corticosterone concentration in mice. Toxicol. Sci. 109:106-112.
19. DeWitt, J. C., Copeland, C. B., Strynar, M. J. and Luebke, R. W. 2008. Perfuorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ. Health Perspect. 116:644-650. (Pubitemid 351864281)
20. DeWitt, J. C., Shnyra, A., Badr, M. Z., Loveless, S. E., Hoban, D., Frame, S. R., Cunard, R., Anderson, S. E., Meade, B. J., Peden-Adams, M. M., Luebke, R. W. and Luster, M. I. 2009b. Immunotoxicity of perfuorooctanoic acid and perfuorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev. Toxicol. 39:76-94.
21. Dickerson, R., Keller, L. H. and Safe, S. 1995. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: Structure-activity studies. Toxicol. Appl. Pharmacol. 135:287-298. (Pubitemid 26031880)
22. Dong, G. H., Zhang, Y. H., Zheng, L., Liu, W., Jin, Y. H. and He, Q. C. 2009. Chronic efects of perfuorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch. Toxicol. 83:805-815.
23. Evans, J. S., Varney, R. F. and Koch, F. C. 1941. Te mouse uterine wet weight method for the assay of estrogens. Endocrinology 28:747-752.
24. Fang, X., Feng, Y., Shi, Z. and Dai, J. 2009. Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic efect of perfuorononanoic acid. Toxicol. Sci. 108:367-376.
25. Fang, X., Zhang, L., Feng, Y., Zhao, Y and Dai, J. 2008. Immunotoxic efects of perfuorononanoic acid on BALB/c mice. Toxicol. Sci. 105:312-321.
26. Faustman, E. M. and Omenn, G. S. 2001. Risk assessment. In: Casarett and Doull's Toxicology: Te Basic Science of Poisons (Klaassen, C. D., Ed), New York: McGraw-Hill Companies, Inc, pp. 83-104.
27. Fort, D., Rodgers, R. L., Guiney, P. D. and Weeks, J. A. 2007. Efects of Perfuorooctane Sulfonate (PFOS) Exposure on Steroidogensis in Juvenile Xenopus (Silurana) tropicalis. Society of Environmental Toxicology and Chemistry\Abstract Book, 28th Annual Meeting, November 11-15, Milwaukee, WI, pp. 231.
28. Fuentes, S., Colomina, M. T., Rodriguez, J., Vicens, P. and Domingo, J. L. 2006. Interactions in developmental toxicology: Concurrent exposure to perfuorooctane sulfonate (PFOS) and stress in pregnant mice. Toxicol. Lett. 164:81-89. (Pubitemid 44382539)
29. Fuentes, S., Colomina, M. T., Vicens, P., Franco-Pons, N. and Domingo, J. L. 2007. Concurrent exposure to perfuorooctane sulfonate and restraint stress during pregnancy in mice: Efects on postnatal development and behavior of the ofspring. Toxicol. Sci. 98:589-598. (Pubitemid 47244827)
30. Giesy, J. P. and Kannan, K. 2001. Global distribution of perfuorooctane sulfonate in wildlife. Environ. Sci. Technol. 35:1339-1342. (Pubitemid 32862501)
31. Grasty, R. C., Wolf, D. C., Grey, B. E., Lau, C. S. and Rogers, J. M. 2003. Prenatal window of susceptibility to perfuorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res. B Dev. Reprod. Toxicol. 68:465-471. (Pubitemid 38055969)
32. Grewal, I. S. and Flavell, R. A. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135. (Pubitemid 28183361)
33. Gupta, M. K., Chiang, T. and Deodhar, S. D. 1983. Efect of thyroxine on immune response in C57Bl/6J mice. Acta Endocrinol. 103:76-80. (Pubitemid 13118727)
34. 1 mice. J. Toxicol. Sci. 34:687-691.
35. Houde, M., Wells, R. S., Fair, P. A., Bossart, G. D., Hohn, A. A., Rowles, T. K., Sweeney, J. C., Solomon, K. R. and Muir, D. C. 2005. Polyfuoroalkyl compounds in free-ranging bottlenose dolphins (Tursiops truncatus) from the Gulf of Mexico and the Atlantic Ocean. Environ. Sci. Technol. 39:6591-6598. (Pubitemid 41266141)
36. Jaattela, M. 1991. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab. Invest., 64(6), 724-742.
37. Jin, Y., Saito, N., Harada, K. H., Inoue, K. and Koizumi, A. 2007. Historical trends in human serum levels of perfuorooctanoate and perfuorooctane sulfonate in Shenyang, China. Tohoku J. Exp. Med. 212:63-70. (Pubitemid 46711727)
38. 14C]- perfuorooctanesulfonate. Fundam. Appl. Toxicol. 4:972-976. (Pubitemid 15182587)
39. Kanda N., Tsuchida T. and Tamaki K. 1996. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol., 106(2):410-415. (Pubitemid 26359912)
40. Kanda N. and Tamaki K. 1999. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol,103(2 Pt 1):282-288. (Pubitemid 29095834)
41. Kannan, K., Franson, J. C., Bowerman, W. W., Hansen, K. J., Jones, P. D. and Giesy, J. P. 2001. Perfuorooctane sulfonate in fsh-eating water birds including bald eagles and albatrosses. Environ. Sci. Technol. 35:3065-3070. (Pubitemid 32881735)
42. Kannan, K., Perrotta, E. and Tomas, N. J. 2006. Association between perfuorinated compounds and pathological conditions in southern sea otters. Environ. Sci. Technol. 40:4943-4948. (Pubitemid 44257457)
43. Kanno, J., Onyon, L., Haseman, J., Fenner-Crisp, P., Ashby, J. and Owens, W. Organisation for Economic Co-operation and Development. 2001. Te OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ. Health Perspect 109:785-794. (Pubitemid 32910300)
44. 1 mice. Toxicol. Sci. 108:110-123.
45. 1 mice. Toxicol. Sci. 103:77-85. (Pubitemid 351524479)
46. Keller, J. M., Kannan, K., Taniyasu, S., Yamashita, N., Day, R. D., Arendt, M. D., Segars, A. L. and Kucklick, J. R. 2005. Perfuorinated compounds in the plasma of loggerhead and Kemp's ridley sea turtles from the southeastern coast of the United States. Environ. Sci. Technol. 39: 9101-9108. (Pubitemid 41741193)
47. Kissa, E. (Ed.). 2001. Fluorinated Surfactants and Repellents, 2nd Ed., New York: Marcel Keller.
48. Klaus, G. G., Holman, M., Johnson-Léger, C., Christenson, J. R. and Kehry, M. R. 1999. Interaction of B-cells with activated T-cells reduces the threshold for CD40-mediated B-cell activation. Int. Immunol. 11:71-79. (Pubitemid 29037590)
49. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A. and Seed, J. 2007. Perfuoroalkyl acids: A review of monitoring and toxicological fndings. Toxicol. Sci. 99:366-394. (Pubitemid 351753056)
50. Lau, C., Tibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Stanton, M. E., Butenhof, J. L. and Stevenson, L. A. 2003. Exposure to perfuorooctane sulfonate during pregnancy in rat and mouse. II: Post-natal evaluation. Toxicol. Sci. 74:382-392. (Pubitemid 36958307)
51. Lee, B. O., Moyron-Quiroz, J., Rangel-Moreno, J., Kusser, K. L., Hartson, L., Sprague, F., Lund, F. E. and Randall, T. D. 2003. CD40, but not CD154, expression on B-cells is necessary for optimal primary B-cell responses. J. Immunol. 171:5707-5717. (Pubitemid 37467185)
52. Lefebvre, D. E., Curran, I., Armstrong, C., Coady, L., Parenteau, M., Liston, V, Barker, M., Aziz, S., Rutherford, K., Bellon-Gagnon, P., Shenton, J., Mehta, R. and Bondy, G. 2008. Immunomodulatory efects of dietary potassium perfuorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats. J. Toxicol. Environ. Health Part A 71:1516-1525.
53. Lehmler, H. J. 2005. Synthesis of environmentally relevant fuorinated sur-factants\a review. Chemosphere 58:1471-1496.
54. Li, Y. Y., Baccam, M., Waters, S. B., Pessin, J. E., Bishop, G. A. and Koretzky, G. A. 1996. CD40 ligation results in protein kinase C-independent activa-tion of ERK and JNK in resting murine splenic B-cells. J. Immunol. 157:1440-1447. (Pubitemid 126449081)
55. H2 cytokine production in DR6-defcient mice. Immunity 15:23-34. (Pubitemid 32728317)
56. Loveless, S. E., Hoban, D., Sykes, G., Frame, S. R. and Everds, N. E. 2008. Evaluation of the immune system in rats and mice administered linear ammonium perfuorooctanoate. Toxicol. Sci. 105:86-96.
57. Luebker, D. J., Hansen, K. J., Bass, N. M., Butenhof, J. L. and Seacat, A. M. 2002. Interactions of fuorochemicals with rat liver fatty acid-binding protein. Toxicology 176:175-185. (Pubitemid 34686958)
58. Luster, M. I., Munson, A. E., Tomas, P. T., Holsapple, M. P., Fenters, J. D., White, K. L. Jr, Lauer, L. D., Germolec, D. R., Rosenthal, G. J. and Dean, J. H. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10: 2-19. (Pubitemid 18055874)
59. Luster, M. I., Portier, C., Pait, D. G., Rosenthal, G. J., Germolec, D. R., Corsini, E., Blaylock, B. L., Pollock, P., Kouchi, Y. and Craig, W. 1993. Risk assessment in immunotoxicology. II. Relationships between immune and host resist-ance tests. Fundam. Appl Toxicol. 21:71-82. (Pubitemid 23225987)
60. Luster, M. I., Portier, C., Pait, D. G., White, K. L. Jr, Gennings, C., Munson, A. E. and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200-210.
61. Mollenhauer, M. A. 2008. Determination of the Role of PPARa in Infammatory Processes Following Perfuorooctane Sulfonate Exposure in a Murine Model. Dissertation, Medical University of South Carolina.
62. Moody C. A. and Field, J. A. 2000. Perfuorinated surfactants and the envi-ronmental implications of their use in fre-fghting foams. Environ. Sci Technol. 34: 3864-3870.
63. Nandakumar, D. N., Koner, B. C., Vinayagamoorthi, R., Nanda, N., Negi, V S., Goswami, K., Bobby, Z. and Hamide, A. 2008. Activation of NF-kappaB in lymphocytes and increase in serum immunoglobulin in hyperthyroidism: Possible role of oxidative stress. Immunobiology 213:409-415. (Pubitemid 351619288)
64. Nelson, D. L., Frazier, D. E. Jr, Ericson, J. E., Tarr, M. J. and Mathes, L. E. 1992. Te efects of perfuorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats. Immunopharmacol. Immunotoxicol. 14:925-938. (Pubitemid 23000959)
65. Noe, S. N., Newton, C., Widen, R., Friedman, H. and Klein, T. W. 2000. Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes. J. Neuroimmunol. 110:161-167
66. OECD. 2002. Hazard Assessment of Perfuorooctane Sulfonate (PFOS) and its Salts. ENV/JM/RD(2002)17/Final. http://www.oecd.org/document/58/0, 2340,en-2649-34379-2384378-1-1-1-1,00.html. Accessed May 12, 2004
67. Okazaki, K., Imazawa, T., Nakamura, H., Furukawa, F., Nishikawa, A. and Hirose, M. 2002. A repeated 28-day oral dose toxicity study of 17alpha-methyltestosterone in rats, based on the 'enhanced OECD Test Guideline 407' for screening the endocrine-disrupting chemicals. Arch. Toxicol. 75:635-642. (Pubitemid 34151150)
68. Olsen, G. W., Burris, J. M., Burlew, M. M. and Mandel, J. H. 2003a. Epidemiologic assessment of worker serum perfuorooctanesulfonate (PFOS) and per-fuorooctanoate (PFOA) concentrations and medical surveillance exami-nations. J. Occup. Environ. Med. 45:260-270. (Pubitemid 36343227)
69. Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhof, J. L. and Zobel, L. R. 2007. Half-life of serum elimination of per-fuorooctanesulfonate, perfuorohexanesulfonate, and perfuorooctanoate in retired fuorochemical production workers. Environ. Health Perspect. 115:1298-1305. (Pubitemid 47471253)
70. Olsen, G. W., Church, T. R., Miller, J. P., Burris, J. M., Hansen, K. J., Lundberg, J. K., Armitage, J. B., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., O'Neill, E. M., Mandel, J. H. and Zobel, L. R. 2003b. Perfuorooctanesulfonate and other fuorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 111:1892-1901. (Pubitemid 37541200)
71. Olsen, G. W., Huang, H. Y., Helzlsouer, K. J., Hansen, K. J., Butenhof, J. L. and Mandel, J. H. 2005. Historical comparison of perfuorooctanesulfonate, perfuorooctanoate, and other fuorochemicals in human blood. Environ. Health Perspect. 113:539-545. (Pubitemid 40711341)
72. Olsen, G. W., Mair, D. C., Church, T. R., Ellefson, M. E., Reagen, W. K., Boyd, T. M., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., Rios, J. A., Butenhof, J. L. and Zobel, L. R. 2008. Decline in perfuorooc-tanesulfonate and other polyfuoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ. Sci. Technol. 42:4989-4995. (Pubitemid 351956443)
73. Owens, J. W. and Ashby, J. 2002. Critical review and evaluation of the utero-trophic bioassay for the identifcation of possible estrogen agonists and antagonists: In support of the validation of the OECD uterotrophic pro-tocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit Rev. Toxicol. 32:445-520. (Pubitemid 35422723)
74. Peden-Adams, M. M., EuDaly, J. G., Dabra, S., EuDaly, A., Heesemann, L., Smythe, J. and Keil, D. E. 2007. Suppression of humoral immunity fol-lowing exposure to the perfuorinated insecticide sulfuramid. J. Toxicol. Environ. Health Part A. 70:1130-1141. (Pubitemid 46900771)
75. Peden-Adams, M. M., Keil, D. E., Romano, T., Mollenhauer, M. A. M., Fort, D. J., Guiney, P. D., Houde, M., Kannan, K., Muir, D. C., Rice, C. D., Stuckey, J., Segars, A. L., Scott, T., Talent, L., Bossart, G. D., Fair, P. A. and Keller, J. M. 2009a. Health efects of perfuorinated compounds\what are the wildlife telling us? Reprod. Toxicol. 27:414-415.
76. Peden-Adams, M. M., Keller, J. M., Eudaly, J. G., Berger, J., Gilkeson, G. S. and Keil, D. E. 2008. Suppression of humoral immunity in mice following exposure to perfuorooctane sulfonate. Toxicol. Sci. 104:144-154. (Pubitemid 351859037)
77. Peden-Adams, M. M., Stuckey, J. E., Gaworecki, K. M., Berger-Ritchie, J., Bryant, K., Jodice, P. G., Scott, T. R., Ferrario, J. B., Guan, B., Vigo, C., Boone, J. S., McGuinn, W. D., DeWitt, J. C. and Keil, D. E. 2009b. Developmental toxicity in white leghorn chickens following in ovo expo-sure to perfuorooctane sulfonate (PFOS). Reprod. Toxicol. 27:307-318.
78. Pérez-Melgosa, M., Hollenbaugh, D. and Wilson, C. B. 1999. Cutting edge: CD40 ligand is a limiting factor in the humoral response to T-cell-dependent antigens. J. Immunol. 163:1123-1127. (Pubitemid 29352725)
79. Qazi, M. R., Bogdanska, J., Butenhof, J. L., Nelson, B. D., DePierre, J. W. and Abedi-Valugerdi, M. 2009a. High-dose, short-term exposure of mice to perfuorooctanesulfonate (PFOS) or perfuorooctanoate (PFOA) afects the number of circulating neutrophils diferently, but enhances the infammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262:207-214.
80. Qazi, M. R., Xia, Z., Bogdanska, J., Chang, S. C., Ehresman, D. J., Butenhof, J. L., Nelson, B. D., DePierre, J. W. and Abedi-Valugerdi, M. 2009b. Te atro-phy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfuorooctanesul-fonate are high-dose phenomena mediated in part by peroxisome prolif-erator-activated receptor-alpha (PPARalpha). Toxicology 260:68-76.
81. Reimers, T. J., Cowan, R. G., Davidson, H. P. and Colby, E. D. 1981. Validation of radioimmunoassay for triiodothyronine, thyroxine, and hydro-cortisone (cortisol) in canine, feline, and equine sera. Am. J. Vet. Res. 42:2016-2021. (Pubitemid 12201784)
82. Renwick, A. G. 1995. Toxicokinetics. In: General and Applied Toxicology: College Edition (Ballantyne, B., Marrs, T., Turner, P., Eds.), New York: Stockton Press, pp. 111-142.
83. Schonbeck, U. and Libby, P. 2001. Te CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58:4-43.
84. Seacat, A. M., Tomford, P. J., Hansen, K. J., Clemen, L. A., Eldridge, S. R., Elcombe, C. R. and Butenhof, J. L. 2003. Sub-chronic dietary toxicity of potassium perfuorooctanesulfonate in rats. Toxicology 183:117-131. (Pubitemid 36005393)
85. Seacat, A. M., Tomford, P. J., Hansen, K. J., Olsen, G. W., Case, M. T. and Butenhof, J. L. 2002. Subchronic toxicity studies on perfuorooc- tanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 68: 249-264. (Pubitemid 34785246)
86. Selgrade, M. K. 2007. Immunotoxicity: Te risk is real. Toxicol. Sci. 100:328-332.
87. Selgrade, M. K. 1999. Use of immunotoxicity data in health risk assess-ments: Uncertainties and research to improve the process. Toxicology 133:59-72. (Pubitemid 29179553)
88. Shipley, J. M., Hurst, C. H., Tanaka, S. S., DeRoos, F. L., Butenhof, J. L., Seacat, A. M. and Waxman, D. J. 2004. Trans-activation of PPARalpha and induction of PPARalpha target genes by perfuorooctane-based chemicals. Toxicol. Sci. 80:151-160. (Pubitemid 38967406)
89. Son, H. Y., Lee, S., Tak, E. N., Cho, H. S., Shin, H. I., Kim, S. H. and Yang, J. H. 2009. Perfuorooctanoic acid alters T-lymphocyte phenotypes and cytokine expression in mice. Environ. Toxicol. 24:580-588.
90. Szocinski, J. L., Khaled, A. R., Hixon, J., Halverson, D., Funakoshi, S., Fanslow, W. C., Boyd, A., Taub, D. D., Durum, S. K., Siegall, C. B., Longo, D. L. and Murphy, W. J. 2002. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: Induction of bax. Blood 100:217-223. (Pubitemid 35177450)
91. Tedder, T. F., Inaoki, M. and Sato, S. 1997. Te CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoim-munity. Immunity 6:107-118. (Pubitemid 27145556)
92. Tibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhof, J. L., Stevenson, L. A. and Lau, C. 2003. Exposure to perfuorooctane sulfonate during pregnancy in rat and mouse. I: mater-nal and prenatal evaluations. Toxicol. Sci. 74:369-381. (Pubitemid 36958306)
93. Ullrich, S. E. 1999. Dermal application of JP-8 jet fuel induces immune suppres-sion. Toxicol Sci., 52(1):61-67.
94. Wetzel, L. T. 1983. Rat Teratology Study, T-3351, Final Report. Hazelton Laboratories America, Inc. Project number 154-160. December 19, 1983 (8EHQ-0399-374). Available on USEPA Public docket AR-226 (No. 226-0014).
95. Xu, Y and Song, G. 2004. Te role of CD40-CD154 interaction in cell immu-noregulation. J. Biomed. Sci. 11:426-438. (Pubitemid 38721026)
96. Yang, Q., Abedi-Valugerdi, M., Xie, Y, Zhao, X. Y, Möller, G., Nelson, B. D. and DePierre, J. W. 2002b. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome prolif-erator, perfuorooctanoic acid. Int. Immunopharmacol. 2:389-397. (Pubitemid 34075427)
97. Yang, Q., Xie, Y, Alexson, S. E., Nelson, B. D. and DePierre, J. W. 2002a. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol 63:1893-1900. (Pubitemid 34603454)
98. Yang, Q., Xie, Y. and Depierre, J. W. 2000. Efects of peroxisome proliferators on the thymus and spleen of mice. Clin. Exp. Immunol. 122:219-226.
99. Yang, Q., Xie, Y, Eriksson, A. M., Nelson, B. D. and DePierre, J. W. 2001. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxi-some proliferator perfuoroctanoic acid in mice. Biochem. Pharmacol. 62:1133-1140. (Pubitemid 32971679)
100. Zheng, L., Dong, G. H., Jin, Y H. and He, Q. C. 2009. Immunotoxic changes associated with a 7-day oral exposure to perfuorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Arch. Toxicol. 83:679-689.